Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This study evaluates the efficacy, anti-tumor effect, and immunogenicity of neoadjuvant enoblituzumab given before radical prostatectomy. Patients will be randomized to enoblituzumab for a total of 12 weeks beginning 84 days before radical prostatectomy or standard of care arms.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Check if you qualify for this prostate cancer clinical trial in Baltimore, MD
If you're searching for prostate cancer treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.